Integrated Biomarker Analysis for 412 RCC patients Treated on the Phase 3 COMPARZ Trial - 100098

Spotlight
Video

Integrated Biomarker Analysis for 412 RCC patients Treated on the Phase 3 COMPARZ Trial

kidneycancer has 449 videos Subscribe Here

Loading........
Description: Martin Voss, MD Memorial Sloan Kettering discusses Integrated Biomarker Analysis for 412 RCC patients Treated on the Phase 3 COMPARZ Trial at the 2017 Kidney Cancer Association symposium in Miami, FL.
Shared By : kidneycancer
Posted on : 11/08/17
Added : 6 months ago
Category : Kidney Cancer



Recommended

Nothing found.